argenx SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010832176
EUR
792.20
10.8 (1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
MDxHealth SA
argenx SE
Sequana Medical NV
Oxurion NV
Celyad Oncology SA
Why is argenx SE ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.90%
  • Poor long term growth as Operating profit has grown by an annual rate 25.03% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -227.81
2
With ROE of 22.71%, it has a Very Expensive valuation with a 8.33 Price to Book Value
  • Over the past year, while the stock has generated a return of 34.68%, its profits have risen by 724.2% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
124.98%
EBIT Growth (5y)
25.03%
EBIT to Interest (avg)
-227.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.25
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
2.90%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
8.33
EV to EBIT
110.92
EV to EBITDA
104.98
EV to Capital Employed
21.54
EV to Sales
14.24
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
19.42%
ROE (Latest)
22.71%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
NET PROFIT(Q)

At EUR 379.81 MM has Grown at 1,361.95%

OPERATING CASH FLOW(Y)

Highest at EUR 360.39 MM

ROCE(HY)

Highest at 25.72%

NET SALES(Q)

Highest at EUR 1,591.9 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.55 %

PRE-TAX PROFIT(Q)

Highest at EUR 452.62 MM

CASH AND EQV(HY)

Highest at EUR 3,346.4 MM

OPERATING PROFIT(Q)

Highest at EUR 295.22 MM

-5What is not working for the Company
INTEREST(Q)

Highest at EUR 2.07 MM

Here's what is working for argenx SE
Pre-Tax Profit
At EUR 452.62 MM has Grown at 668.6%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (EUR MM)

Net Profit
At EUR 379.81 MM has Grown at 1,361.95%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (EUR MM)

Net Sales
Highest at EUR 1,591.9 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (EUR MM)

Net Sales
At EUR 1,591.9 MM has Grown at 96.44%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (EUR MM)

Operating Profit Margin
Highest at 18.55 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at EUR 452.62 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (EUR MM)

Operating Cash Flow
Highest at EUR 360.39 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (EUR MM)

Operating Profit
Highest at EUR 295.22 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (EUR MM)

Cash and Eqv
Highest at EUR 3,346.4 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation
At EUR 12.14 MM has Grown at 47.64%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (EUR MM)

Here's what is not working for argenx SE
Interest
Highest at EUR 2.07 MM
in the last five periods and Increased by 62.39% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)